from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0343/iniC

LFCtreatmentdescriptionclass of inhibitor

0.125

Amikacinug/mL Amikacintranslation

-0.070

Cap5-10ug/mL Capreomycintranslation

0.104

Rox10-50 ug/mL Roxithromycintranslation

-0.767

SM2-5 ug/mL Streptomycintranslation

0.913

Tet5-10 ug/mL Tetracyclinetranslation

-0.110

Rif0.2-5ug/mL Rifampicintranscription

0.332

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.155

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.075

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.222

CPZ10-50 ug/mL Chlorpromazinerespiration

0.801

Clofazimine10-13 ug/mL Clofaziminerespiration

0.152

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.320

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.740

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.119

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.131

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.576

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.345

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.643

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.397

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.736

KCN5-20 ug/mL Potassium cyaniderespiration

-1.193

NaN30.2-2 mM Sodium aziderespiration

0.104

Nigericin50 uM Nigericinrespiration

0.461

TRC10-150 ug/mL Triclosanrespiration

1.142

TRZ10-25 ug/mL Thioridazinerespiration

0.648

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.532

menadione6-10 ug/mL Menadionerespiration

-0.100

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.429

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.452

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.926

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.217

NRP_1Non-replicating persistence stage 1dosRassociated

-1.022

Amp0.2mg/mL AmpicillincellWall

-0.075

Cephalexin20-100 ug/mL CephalexincellWall

0.621

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.814

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.055

EMB10-20 ug/mL EthambutolcellWall

1.122

Eta12-40 ug/mL EthionamidecellWall

0.823

INH0.2-0.4 ug/mL IsoniazidcellWall

1.230

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.057

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.157

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.453

BZA0.12 mg/mL BenzamidearomaticAmides

-0.485

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.602

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.096

H2O24 mM hydrogen peroxideDNAdamaging

0.045

Levo10 ug/mL LevofloxacinDNAdamaging

-0.734

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.556

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.636

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.647

UVUV-irradiationDNAdamaging

-0.241

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.186

Antimycin12.5-50 ug/mL Antimycin A?

-0.468

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.115

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.042

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.969

PA8240.2-2 ug/mL PA-824?

0.063

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.489

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.405

Verapamil50 uM Verapamil?

-0.345

mercaptoethanol2 mM 2-Mercaptoethanol?

0.191

methoxatin10-20 ug/mL Methoxatin?